Dr. Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product. As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), the Hyderabad-based drug firm is voluntarily recalling 1,752 bottles (1,000 counts) of 40 mg Esomeprazole Magnesium delayed-release capsules in the US.
The ongoing Class III recall is on account of Discolouration and because the product contains brown pellets. As per the US health regulator, a class III recall is initiated in a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. The recalled product lot has been manufactured at company’s Bachupally manufacturing facility in Telangana and is being recalled by the company's US-based arm.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
